Yatırımcı.AI

BISTTRYOct 16, 18:19Live

Türkiye Şişe ve Cam Fabrikaları A.Ş.

SISE Price Target 2026Türkiye Şişe ve Cam Fabrikaları A.Ş.

Star MarketHoldings and Investment Companies
36.16−1.10 (−2.95%)
Volume
TRY 1.2B
Day range
36.04 – 36.80
Previous close
37.26
Market cap
TRY 110.8B

Last updated: Source: Borsa Istanbul, 15-minute delayed

The average price target of 12 brokers for SISE is TRY 62.97 (August 18, 2026), implying 74.15% from the last price.

Broker price targets, buy-hold-sell ratings and model portfolio status for Türkiye Şişe ve Cam Fabrikaları A.Ş. (SISE). The average target is compared with the current price to derive the implied upside; the AI fair value estimate is shown for comparison.

Last updated: Source: Broker research

Analyst Consensus

Average target
62.97 TL
Median target
63.79 TL
Highest target
71.05 TL
Lowest target
54.57 TL
Upside
74.15%
Buy / Hold / Sell
7 / 4 / 0

Broker Price Targets

VakifVakifAugust 18, 2026Buy64.7078.93%
AlnusAlnusAugust 18, 2026Buy62.8773.87%
HalkHalkAugust 18, 2026Buy68.5089.44%
DenizDenizAugust 18, 2026Hold60.0065.93%
GedikGedikAugust 18, 2026Outperform68.0088.05%
SekerSekerAugust 18, 2026Buy65.0079.76%
GarantiGarantiAugust 18, 2026Market perform57.0057.63%
AtaAtaAugust 5, 2026Hold54.5750.91%
OyakOyakAugust 4, 2026Market perform57.0057.63%
TEB YatirimTEB YatirimJune 23, 2026Outperform58.0060.40%
AhlatciAhlatciApril 13, 2026Buy71.0596.49%
GCMGCMFebruary 17, 2026ÖNERİ YOK69.0090.82%
UnluUnluJanuary 12, 2026Hold56.90—

AI Fair Value

AI fair value
43.28 TL
Upside
19.69%
Model date
July 21, 2026
Analyst price targets for all stocks

Frequently Asked Questions

12 brokers have an average target of TRY 62.97 for SISE, with 7 buy, 4 hold and 0 sell ratings.

The highest price target for SISE is TRY 71.05, the lowest is TRY 54.57 and the median is TRY 63.79.

Our AI fair value model estimates TRY 43.28 for SISE, a difference of 19.69% from the current price. The model was updated on July 21, 2026. Not investment advice.

No. Price targets are opinions from broker research reports, provided for information only, not a recommendation to buy or sell.